13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q1 2020. See the latest, Q2 2026 →
Reported value
$377.87B
−21% on the quarter before
Positions
1,890
172 new · 283 sold out
Top 10
17.2%
of the value
Est. gain
−$86.05B
on stocks held all quarter
Est. return
−20.5%
on those stocks since Q4 2019
Positions as of Mar 31, 2020, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 32% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2019. Striped tiles are options.
Largest buys
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Mcdonalds Corp~$1.54BAdded · 0.9% → 1.3%+9,342,704 shares
- Becton Dickinson & Co~$1.35BAdded · 0.1% → 0.5%+5,869,236 shares
- Trane Technologies Plc~$1.21BNew · 0.0% → 0.3%+14,654,313 shares
- Texas Instruments~$1.16BAdded · 0.3% → 0.6%+11,560,600 shares
- Amazon~$1.10BAdded · 0.8% → 1.4%+563,991 shares
- Apple~$1.05BAdded · 1.4% → 1.8%+4,148,565 shares
- Cisco~$1.03BAdded · 0.7% → 1.0%+26,179,953 shares
- TSMC~$843.7MAdded · 0.1% → 0.4%+17,654,228 shares
- Netflix~$817.3MAdded · 0.1% → 0.3%+2,176,569 shares
- Pfizer Inc~$814.4MAdded · 1.6% → 1.9%+24,950,461 shares
Largest sells
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Verizon Communications Inc~$1.83BCut · 1.4% → 1.1%−34,100,146 shares
- Exxon Mobil Corp~$1.38BCut · 0.8% → 0.2%−36,419,839 shares
- Cvs Health Corp~$1.16BCut · 0.6% → 0.3%−19,502,723 shares
- Eli Lilly~$1.15BCut · 1.2% → 1.3%−8,322,982 shares
- Chevron Corp New~$1.15BCut · 0.9% → 0.4%−15,803,732 shares
- Suncor Energy Inc New~$1.13BCut · 0.5% → 0.0%−71,382,359 shares
- Ingersoll-Rand Plc~$986.6MSold out · 0.2% → 0.0%−7,422,388 shares
- Intercontinental Exchange In~$699.0MCut · 0.3% → 0.1%−8,655,910 shares
- Teva Pharmaceutical Inds Ltd~$698.0MCut · 0.2% → 0.0%−77,682,058 shares
- Lowes Cos Inc~$691.8MCut · 0.5% → 0.2%−8,040,093 shares
Holdings
As of Mar 31, 2020. Changes are in shares against Dec 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −2.7% · price +0.0% | 2.9% | $11.13B | +$705,240 | ||||||||
| Unitedhealth Group IncCOM · shares +0.4% · price −15.2% | 2.2% | $8.17B | −$1.46B | ||||||||
| Pfizer IncCOM · shares +13% · price −16.7% | 1.9% | $7.14B | −$1.27B | ||||||||
| AppleCOM · shares +18% · price −13.4% | 1.8% | $6.85B | −$897.1M | ||||||||
| Medtronic PlcSHS · shares −2.2% · price −20.5% | 1.6% | $6.07B | −$1.57B | ||||||||
| AmazonCOM · shares +26% · price +5.5% | 1.4% | $5.31B | +$219.8M | ||||||||
| AlphabetCAP STK CL A · shares +12% · price −13.2% | 1.4% | $5.21B | −$710.1M | ||||||||
| Jpmorgan Chase & CoCOM · shares −6.1% · price −35.4% | 1.3% | $5.09B | −$2.79B | ||||||||
| Bk Of America CorpCOM · shares +1.4% · price −39.7% | 1.3% | $5.02B | −$3.26B | ||||||||
| Eli LillyCOM · shares −19% · price +5.5% | 1.3% | $5.00B | +$262.6M | ||||||||
| Mcdonalds CorpCOM · shares +45% · price −16.3% | 1.3% | $4.97B | −$667.6M | ||||||||
| Coca Cola CoCOM · shares +11% · price −20.1% | 1.2% | $4.54B | −$1.03B | ||||||||
| Bristol-Myers Squibb CoCOM · shares −9.5% · price −13.2% | 1.1% | $4.21B | −$638.0M | ||||||||
| Verizon Communications IncCOM · shares −30% · price −12.5% | 1.1% | $4.19B | −$598.4M | ||||||||
| Home Depot IncCOM · shares +19% · price −14.5% | 1.1% | $4.16B | −$593.5M | ||||||||
| Johnson & JohnsonCOM · shares +11% · price −10.1% | 1.1% | $4.01B | −$406.6M | ||||||||
| Comcast Corp NewCL A · shares −3.9% · price −23.5% | 1.0% | $3.96B | −$1.22B | ||||||||
| Lockheed Martin CorpCOM · shares +0.1% · price −13.0% | 1.0% | $3.87B | −$575.4M | ||||||||
| Tjx Cos Inc NewCOM · shares +21% · price −21.7% | 1.0% | $3.86B | −$888.6M | ||||||||
| American TowerCOM · shares +0.03% · price −5.3% | 1.0% | $3.80B | −$210.7M | ||||||||
| CiscoCOM · shares +38% · price −18.0% | 0.98% | $3.72B | −$591.8M | ||||||||
| Merck & Co. IncCOM · shares −16% · price −15.4% | 0.97% | $3.68B | −$670.6M | ||||||||
| IntelCOM · shares −2.0% · price −9.6% | 0.94% | $3.55B | −$375.6M | ||||||||
| Union Pac CorpCOM · shares +13% · price −22.0% | 0.91% | $3.43B | −$855.4M | ||||||||
| Abbott LabsCOM · shares +12% · price −9.2% | 0.90% | $3.41B | −$306.9M | ||||||||
| Total · 1,890 positions | 100% | $377.87B | −$86.05B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2019 to Q1 2020: 1,652 stocks held throughout, down $86.05B (−20.5%).
- Eli Lilly+$262.6M+6%
- Regeneron Pharmaceuticals+$232.0M+30%
- Amazon+$219.8M+6%
- Vertex Pharmaceuticals Inc+$141.3M+9%
- Forty Seven Inc+$118.2M+142%
- Pnc Finl Svcs Group Inc−$1.38B−40%
- Unitedhealth Group Inc−$1.46B−15%
- Medtronic Plc−$1.57B−21%
- Jpmorgan Chase & Co−$2.79B−35%
- Bk Of America Corp−$3.26B−40%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 21 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |